FDA advisers vote against sleep peptide as they debate safety and health claims
MarketWatch· Jaimy Lee· Jul 24, 2026 · 5:26 PM
An FDA advisory committee is meeting for two days to discuss whether seven peptides — which have become popular in wellness circles — should be allowed to be compounded.
This is a summary. Read the complete story at MarketWatch below.
Read full article at MarketWatchRelated Stories
markets30 minutes ago
‘People in the U.S. need to wake up’: As a mortgage loan officer, I rejected wealthy couples due to overspending. We’re all heading for trouble.
“We’d better get real quick or we’re going to have a financial crisis that makes the Great Recession of 2008 look like a picnic.”
MarketWatch
markets43 minutes ago
Musk hints TSMC may join his mega chip venture, and Intel’s stock is taking a hit
Intel shares are taking a hit on Monday after a report that TSMC may help with Elon Musk’s Terafab factory.
MarketWatch
marketsabout 1 hour ago
An AI ‘reality check’ may take the S&P 500 to 5,000. Here are the trades to make, this strategist says.
Keep an eye on artificial-intelligence spending in the upcoming earnings season, Panmure Liberum’s Joachim Klement said.
MarketWatch